Navigation Links
FDA approves IND on Lead Product M6G

CAMBRIDGE, England, 26th April 2007 - CeNeS Pharmaceuticals plc (LSE: CEN), the Cambridge based biopharmaceutical company, today announces that the United States Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for the clinical development of morphine-6-glucuronide (M6G), its novel drug for the treatment of post-operative pain. Earlier this year, CeNeS announced results of a Phase III study of M6G in Europe in over 500 patients with post-operative pain. The study demonstrated that M6G provided equivalent pain relief to morphine but induced significantly less post-operative nausea and vomiting (PONV). The opening trial under this IND will be a Phase I pharmacokinetic study in volunteers. This study is required by the FDA as is an additional pre-clinical toxicology analysis before progressing to Phase III trials. CeNeS is currently completing the protocol design of the first US Phase III trial. The filing of the IND enhances the package of data already available to potential US partners for review. Neil Clark, Chief Executive of CeNeS, said:

"The FDA's approval of our IND application for M6G is a major landmark in CeNeS' clinical development programme. North America is an attractive market for our drug candidate and M6G is clearly positioned to be a genuine alternative to standard morphine therapy."

For more information please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466

JM Finn Geoff Nash Tel: +44(0) 207 628 9688

Financial Dynamics Ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113

About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the development and commercialisation of drugs for pain control, sedation and other CNS disorders such as Parkinson's disease. The company is based in Cambridge, England. For further information visit the CeNeS web site: '"/>




Page: 1 2

Related medicine technology :

1. FDA approves MyocondaR IND for MAP in Crohns Disease
2. Pieris Progresses Proprietary Asthma Program: Validation of Pulmonary Delivery of Anticalin-Based Protein Product Candidate
3. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
4. CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
5. Publication Confirms that EpCAM, the Target for Two of Micromets Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers
6. HepaLifes PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference
7. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
8. PromegaExpress Expands Easy Access to Products with New Cabinet
9. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
10. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
11. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: FDA approves IND Lead Product
(Date:12/1/2009)...wswire-USNewswire/ -- ,, Overweight Children M..., A study from The Children,s Hospital at Montefi...verweight may be causing damage to their spines. R... adolescents between the ages of 12 and 20 who com...al over a four-year period. The results showed an ...
(Date:11/30/2009)... 30 Nonin Medical, Inc., a leading...nd the inventor of fingertip pulse oximetry, was a...oduct Line Strategy Award in Remote Patient Monito...mote physiological monitoring, Nonin Medical was a...er of telemedicine monitoring equipment. ,, The...
(Date:11/30/2009)...ewswire/ -- Breast-Specific Gamma Imaging (BSGI) h...chnique for the detection of ductal carcinoma in s... BSGI is a molecular breast imaging technique that... discover very early stage cancers. According to f...he Radiological Society of North America (RSNA), B...
Breaking Medicine Technology:Tuesday, Dec. 1: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 2Tuesday, Dec. 1: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 3Nonin Medical is Recognized by Frost & Sullivan for Remote Patient Monitoring Leadership 2Nonin Medical is Recognized by Frost & Sullivan for Remote Patient Monitoring Leadership 3Breast-Specific Gamma Imaging Proves Highly Sensitive for the Detection of Ductal Carcinoma In Situ 2Air Pollution May Raise Blood Pressure 57069 1Air Pollution May Raise Blood Pressure 57069 2Sun Pharmaceutical Announces Expiration of HSR Act Waiting Period for Taro Tender Offer 57066 1Sun Pharmaceutical Announces Expiration of HSR Act Waiting Period for Taro Tender Offer 57066 2Sun Pharmaceutical Announces Expiration of HSR Act Waiting Period for Taro Tender Offer 57066 3Target House 28R 29 Celebrates 10 Years with a Celebrity Studded Big Top Birthday Party 57062 1Target House 28R 29 Celebrates 10 Years with a Celebrity Studded Big Top Birthday Party 57062 2Target House 28R 29 Celebrates 10 Years with a Celebrity Studded Big Top Birthday Party 57062 3Target House 28R 29 Celebrates 10 Years with a Celebrity Studded Big Top Birthday Party 57062 4Target House 28R 29 Celebrates 10 Years with a Celebrity Studded Big Top Birthday Party 57062 5Target House 28R 29 Celebrates 10 Years with a Celebrity Studded Big Top Birthday Party 57062 6
...y observed through 2.5 years of LymphoStat... observed increase in rates of adverse events, ser... over 2.5 years of LymphoStat-B treatment -, ROCK...sdaq: HGSI ) today announced the presentation of ...Stat-B(R) (belimumab) achieved a sustained,improve...
... Every day brings new reports of students becomin...methicillin-resistant staphylococcus aureus),a pot...ily acquired in,public schools, universities and c...abscesses and/or infections. While MRSA is more p...,those with low immune systems, children and young...
Other Medicine Technology:Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 2Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 3Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 4Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 5Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 6Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 7Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus 8An Open Letter to Parents, Students, School Administrators, & Health Care Officials from Soapopular(R) 2An Open Letter to Parents, Students, School Administrators, & Health Care Officials from Soapopular(R) 3
(Date:12/1/2009)... with age are more likely to engage in risky healt...d negative view of the aging process may act as a ...em to make the most of the present in anticipation... John Garry and Dr. Maria Lohan from Queen,s Unive...ine in Springer,s Journal of Happiness Studies . ...
(Date:12/1/2009)...erous lesions, researchers say , , TUESD...asound, elastography helps distinguish between can...necessary biopsies, U.S. researchers have found. ,...opsied turn out to be benign, according to the Ame...to improve specificity with ultrasound, and elasto...
(Date:12/1/2009)... drop worldwide, but gains at risk. , ...easles Initiative partners -- the American Red Cr...on, the United Nations Foundation, UNICEF, and the...he latest global health achievement during a press...0:00 a.m. ET/16:00 CET. There will be time for qu...
(Date:12/1/2009)...PRNewswire/ -- For most working-age Americans, the.... It is this ability to earn an income that make... also to plan and save for tomorrow,s college and ...thwestern Mutual survey , only 10 percent of adul...their income by insuring it in the event of disabi...
(Date:12/1/2009)...re/ -- , - At ECPA,s Food Supply Forum, E...es of Agriculture Will Require Science-Based Solut...tific Adviser to the UK government,asserted that ... and have a,sound evidence basis. "Having a chief ... at all stages of policy development has real pote...
Breaking Medicine News(10 mins):Health News:Binge drinking youths find getting old a drag 2Health News:Ultrasound With Elastography May Cut Down on Biopsies 2Health News:**MEDIA ADVISORY** Measles Initiative to Announce Major Achievement in Public Health 2Health News:Northwestern Mutual Survey Reveals That Most Americans Are Putting Their Income at Risk 2Health News:Northwestern Mutual Survey Reveals That Most Americans Are Putting Their Income at Risk 3Health News:Food Security to be the Top Issue for EU's Science Chief 2
... the cancer drugs of tomorrow and how will they be...onal Conference on Molecular Targets and Cancer Th...to these and other pressing questions regarding em...bodies and small inhibitory molecules. New therape...
...5, 2007- According to a small-scale, in-office, ob...significantly different perceptions of the importa...s, particularly regarding the patients most concer...presented recently at the 20th annual U.S. Psychia...
...diseases are a group of 13 infectious diseases, in...sickness and trachoma, which affect more than 1 bi...me poverty. In a study published in the most recen...re of them simultaneously for only pennies per dos...
... Technologies, Inc.,(Amex: TQ ) announced that it...Inc. has entered into a Services Agreement (the "A...orate Claim-Remedi,s products into,TriCap,s ARxCha...ccounts receivables. ARxChange represents a core,s...
...ocus on its vaccine business and reduce cash burn,... NVAX ) announced today that it has agreed with Al... agreement for Estrasorb. Estrasorb was,previously...o severe vasomotor symptoms (hot flashes) associat...
...to offer two of five CDC-recommended smoking ...HINGTON, Oct. 25 A nationwide survey of employers... ranked smoking as one of,the greatest priority he...e Control and Prevention (CDC). (1) The results,we...
Other Medicine News:Health News:Targets on the horizon: Emerging therapies and novel targets 2Health News:Targets on the horizon: Emerging therapies and novel targets 3Health News:Targets on the horizon: Emerging therapies and novel targets 4Health News:Targets on the horizon: Emerging therapies and novel targets 5Health News:Targets on the horizon: Emerging therapies and novel targets 6Health News:Targets on the horizon: Emerging therapies and novel targets 7Health News:Psychiatrists, parents significantly differ in ADHD, psychiatric comorbidities perceptions 2Health News:Study finds multiple neglected tropical diseases effectively treated with drugs 2Health News:Cash Technologies Subsidiary Signs Services and Licensing Agreement With TriCap Health Group 2Health News:Cash Technologies Subsidiary Signs Services and Licensing Agreement With TriCap Health Group 3Health News:Novavax and Allergan Terminate Manufacturing Supply Agreement for Estrasorb 2Health News:Novavax and Allergan Terminate Manufacturing Supply Agreement for Estrasorb 3Health News:New Survey Shows Majority of Employers Rank Smoking as One of Their Greatest Priority Health Issues, But Only 2 Percent Provide Comprehensive Smoking Cessation Benefits for Employees 2Health News:New Survey Shows Majority of Employers Rank Smoking as One of Their Greatest Priority Health Issues, But Only 2 Percent Provide Comprehensive Smoking Cessation Benefits for Employees 3Health News:New Survey Shows Majority of Employers Rank Smoking as One of Their Greatest Priority Health Issues, But Only 2 Percent Provide Comprehensive Smoking Cessation Benefits for Employees 4Health News:New Survey Shows Majority of Employers Rank Smoking as One of Their Greatest Priority Health Issues, But Only 2 Percent Provide Comprehensive Smoking Cessation Benefits for Employees 5
...gned To Safely And Easily Cut Foldable Lenses Thro... Incision., ,Specially Designed To Cut And Rem...With Ease With One Instrument., ,Ideal For Cut...ged, The Wrong Diopter Power, Or Need To BeExchang...
...2108 : Designed To Be Used With The Gills Nomogra...The Cornea For Making Limbal Relaxing Incisions.,...ls Nomograms. 6mm & 8mm Chord Length Radials Place...ns.5mm Inner Circle Assists In Sizing A Precise Ca...
...ue Locking Screw Mechanism Allows Quick & Easy Adj...r Maximum Exposure And Patient Comfort (Unlike Spr...ement & Setting Of The Blades. No Laborious, Tedio...es. , ,Available In Either Solid Blade Or Open...
...ue Reversible Speculums Designed To Rest Either Na...ms Over, Allowing Eyelids To Be Opened From Narrow...e.,Open And Close With One-Handed Operation, ...The Globe During Clear Corneal And Scleral Tunnels...
Medicine Products: